The National Cancer Institute (NCI) is offering this grant to advance the understanding of Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus-8 (HHV-8). This grant is for investigating the modes of KSHV transmission, the biology of initial infection steps, and the associated risk factors. The primary purpose is to inform and further efforts aimed at reducing or eliminating KSHV transmission. This research is crucial for preventing Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases, particularly in populations living with or at high risk of developing HIV infection.
Opportunity ID: 329190
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-20-046 |
| Funding Opportunity Title: | Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Sep 23, 2020 |
| Last Updated Date: | Sep 23, 2020 |
| Original Closing Date for Applications: | Dec 14, 2021 |
| Current Closing Date for Applications: | Dec 14, 2021 |
| Archive Date: | Jan 19, 2022 |
| Estimated Total Program Funding: | $3,000,000 |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Private institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) County governments Small businesses City or township governments Public and State controlled institutions of higher education State governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) intends to advance our understanding of: the modes of transmission of Kaposi sarcoma-associated herpesvirus (KSHV), also called human herpesvirus-8 (HHV-8); the biology of the initial steps of infection; and the risk factors for infection. Such studies should inform and advance efforts to reduce or eliminate KSHV transmission and thus prevent Kaposi sarcoma (KS), KSHV-associated multicentric Castleman disease (MCD), primary effusion lymphoma (PEL), and other KSHV-induced diseases in populations living with HIV or at high risk of developing HIV infection. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-20-046.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00263529 | Nov 13, 2020 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269823 | Oct 28, 2021 | Dec 14, 2021 | View |
Package 1
Mandatory forms
329190 RR_SF424_2_0-2.0.pdf
329190 PHS398_CoverPageSupplement_5_0-5.0.pdf
329190 RR_OtherProjectInfo_1_4-1.4.pdf
329190 PerformanceSite_2_0-2.0.pdf
329190 RR_KeyPersonExpanded_2_0-2.0.pdf
329190 PHS398_ResearchPlan_4_0-4.0.pdf
329190 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
329190 RR_Budget_1_4-1.4.pdf
329190 RR_SubawardBudget30_1_4-1.4.pdf
329190 PHS398_ModularBudget_1_2-1.2.pdf
329190 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
329190 RR_SF424_5_0-5.0.pdf
329190 PHS398_CoverPageSupplement_5_0-5.0.pdf
329190 RR_OtherProjectInfo_1_4-1.4.pdf
329190 PerformanceSite_4_0-4.0.pdf
329190 RR_KeyPersonExpanded_4_0-4.0.pdf
329190 PHS398_ResearchPlan_4_0-4.0.pdf
329190 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
329190 RR_Budget_3_0-3.0.pdf
329190 RR_SubawardBudget30_3_0-3.0.pdf
329190 PHS398_ModularBudget_1_2-1.2.pdf
329190 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
